Perioperative transfusion management in patients with sickle cell anaemia undergoing a total hip arthroplasty. Is there a role of red-cell exchange transfusion? A retrospective study in the CHU of Fort-de-France Martinique

被引:7
作者
Amar, K. Ould [1 ]
Rouvillain, J. -L. [2 ]
Loko, G. [3 ]
机构
[1] Etab Transfus Sanguine Martinique, Rue Coup De Main,CS 40511, F-97206 Fort De France, Martinique, France
[2] CHU Ft de France, Dept Orthopedie & Traumatol, F-97261 Fort De France, Martinique, France
[3] Ctr Hosp Mangot Vulcin, CID, F-97232 Lamentin, Martinique, France
关键词
Sickle cell anaemia; Exchange transfusion; Total hip arthroplasty; Transfusion and orthopaedic surgery; ORTHOPEDIC-SURGERY; DISEASE; COMPLICATIONS; OSTEONECROSIS; THERAPY;
D O I
10.1016/j.tracli.2012.11.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. - We conducted a retrospective study to examine the optimal regimen of transfusion and whether preoperative transfusion is needed in patients with Sickle cell anaemia (SCA) undergoing a Total hip arthroplasty (THA). Then, we assessed the incidence of perioperative complications rates among patients assigned to different transfusion regimens to propose finally the safety transfusion protocol. Background. - Preoperative transfusions are usually given to reduce or prevent perioperative complications to SCA patients undergoing THA. There is no consensus however on the best regimen of transfusion. Study design and methods. - During the period of 2000 to 2010, 14 patients with SCA (sex-ratio 0.4) with a mean age of 36 years underwent 16 THA (primary or revision). Three groups were differentiated according preoperatively protocol transfusion. Group 1: exchange transfusion (EXT), group 2: simple transfusion (ST), group 3: no transfusion (NT). Results. - Overall, preoperative transfusion was performed in 43.7% of cases and complications rate was 50%. In the group 1 (EXT) including five patients (31%), severe complications occurred in four patients (80%). in the group 2, including two patients (12.5%), no complications were observed. In the group 3, including nine patients (56%), complications occurred in four procedures (44.5%), the half of them were haemolytic complications. Conclusion. - Our results support the decision to transfuse, ST, preoperatively only if the patient is significantly below their steady-state haemoglobin (Hb) level. Transfusion can be used intraoperatively according Hb level and/or the blood loss volume. Exchange transfusion appeared mostly to be related to postoperative morbidity rates. (c) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:30 / 34
页数:5
相关论文
共 16 条
  • [1] Al-Jaouni SK, 2006, BAHRAIN MED B, V28
  • [2] Al-Mousawi F, 2004, BAHRAIN MED B, V26, P1
  • [3] Al-Samak Zahra M., 2008, Middle East Journal of Anesthesiology, V19, P983
  • [4] Assessment of the use of transfusion therapy and complications in orthopedic surgery in patients with sickle-cell anemia:: retrospective study
    Amar, AKO
    Delattre, O
    Godbille, C
    Béra, O
    Halbout, PA
    Catonné, Y
    [J]. TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2003, 10 (02) : 61 - 66
  • [5] Preoperative transfusion in sickle cell disease: a survey of practice in England
    Buck, J
    Casbard, A
    Llewelyn, C
    Johnson, T
    Davies, S
    Williamson, L
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 (01) : 14 - 21
  • [6] Sickle cell disease and anesthesia
    Firth, PG
    Head, CA
    [J]. ANESTHESIOLOGY, 2004, 101 (03) : 766 - 785
  • [7] Total THA in adult osteonecrosis related to sickle cell disease
    Hernigou, Philippe
    Zilber, Sebastien
    Filippini, Paolo
    Mathieu, Gilles
    Poignard, Alexandre
    Galacteros, Frederic
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2008, 466 (02) : 300 - 308
  • [8] Hirst C, 2012, COCHRANE DATABASE SY
  • [9] Marulanda German A, 2009, J Orthop Surg (Hong Kong), V17, P346
  • [10] Mukisi-Mukaza M, 2000, ORTHOPEDICS, V23, P357